¿POR QUÉ RECLAMAN LAS UNIVERSIDADES PÚBLICAS?
El 9/4/24 el CIN @CINoficial aprobó por unanimidad el documento "Convocamos a defender la educación pública, la ciencia y el sistema universitario nacional"
🧵 con resumen de los reclamos.
Argentine public universities are on the verge of collapse. New government forces us to operate with the same budget as in 2023. With annual inflation of 288%, it means 25.8% of the resources. If the situation is not reversed, we can't remain open beyond May 2024.
Happy to share our last publication on Tau miRNAs for tauopathies, congrats to all members of the team for this awasome work. @MolTherapy@CONICETDialoga@CurePSP
@ciencia_ar
@genetherapynet
https://t.co/poyWBBloJd
Felices de un nuevo reconocimiento a la UBA, contra viento y marea sigue siendo la mejor universidad del país!
Happy to share a new recognition to our beloved UBA, in spite of all constraints still the best university of Argentina and among the top 100 worldwide
📢Call for ALBA-@ELSneuroscience Award Lecture on Brain Sciences 2023 is now open! Nominate a neuroscientist working in countries underrepresented among neuroscience publications & conferences.
👉🏽Read more about past winners & apply:https://t.co/oNsaN83ttj
📅Deadline: 3 March '23
📣Call for the ALBA-@FensKavliNet#Diversity#Prize 2023 is open! Nominate a scientist who has made outstanding contributions to promoting #equality and #diversity in #neuroscience.
How to apply: https://t.co/BCZgj8Wc5z
Nomination deadline: 15 January 2023
5:30 am, NYC ... tech check to give a @CurePSP presentation at the 59th Congreso Argentino de Neurología. Wish I was there in person. It's an honor to be in this session w/ @GunterHoglinger @GGKovacsBrain@eleavale73 and so many other leading researchers and clinicians.
Register for #Neuro22 & join us as we highlight the work of leading neuroscientists, discuss research updates, & more. We welcome all researchers interested in preclinical & clinical neuroscience! @LMU_Uniklinikum @Cambridge_Uni@andreaquattro@Ed_Jabbari
https://t.co/kYMKkhGBg2
Los resultados del estudio publicado esta semana explican por qué muchos más de los que acumulamos placas amiloides cerebrales no desarrollamos demencia y por qué los anticuerpos que reducen las placas amiloides no pueden funcionar. Una alternativa existe.
https://t.co/52g6ctD3wA
Simposio #LATBrain 2022, bajo el título: “Estado actual y retos de las investigaciones en enfermedades neurodegenerativas y epilepsia en Latinoamérica”, a realizarse de manera virtual el 27 y 28 de octubre próximo, en la plataforma de la UNAH. https://t.co/bB2I1xjV1K hilo...